Navigation Links
Shire Second Quarter Product Sales Up 16%
Date:8/1/2012

$520 million (Q2 2011: $440 million) as higher cash receipts from product sales, including significant cash receipts from government-supported healthcare providers in Spain in Q2 2012, more than offset increased payments for operating expenses and sales deductions.

Free cash flow, also a Non GAAP measure, was up 84% to $433 million (Q2 2011: $235 million), due to higher cash generation and lower cash tax payments in Q2 2012 compared to Q2 2011.

On a US GAAP basis, net cash provided by operating activities was up 64% to $466 million (Q2 2011: $284 million).
  • Reflecting our strong cash generation, net cash at June 30, 2012 was $18 million (December 31, 2011: net debt of $468 million).

  • OUTLOOK


    We have made a strong start to the year and Shire is on track to deliver double digit full year earnings growth in 2012, while continuing to invest in our business to support sustained future growth from the significant market opportunities that we have identified.

    For the full year we now expect product sales growth to be in the low teens. This reflects the fact that foreign exchange movements are impacting the reported growth of some of our products, but also our expectation that ADDERALL XR® will remain competitive in the US market following the approval of a generic competitor.

    Full year royalties and other revenues are now expected to be 25% to 35% lower year on year, a change from previous guidance as a result of lower royalties from Impax Laboratories Inc.

    Taken together, we expect that total revenues will still show double digit growth in 2012.

    We still anticipate marginal dilution of Non GAAP gross margins in the full year.

    We will continue to invest in the longer term growth prospects of the business but we are reducing the 2012 rate of year on year growth of combined Non GAAP R&D and SG&A expenditure to between 10% and 12%.

    Influenced
    '/>"/>

    SOURCE Shire plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

    Related medicine technology :

    1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
    2. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
    3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
    4. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
    5. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
    8. The Female Health Company Reports Second Quarter Operating Results
    9. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
    10. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
    11. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
    (Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
    (Date:8/20/2014)... -- Trovagene, Inc. (NASDAQ:   TROV), a developer of ... clinical studies will be presented at the 29th International ... for the detection of high risk strains of Human ... place in Seattle from August ... new U.S. patent was issued earlier this year for ...
    Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
    ... , , , ... Exposure of Type I Diabetes Patients to Oramed,s Oral,Insulin and of a First-in-Humans Study With ... Oramed Pharmaceuticals, ... of the,American Diabetes Association currently being held in Orlando, Florida . Dr., Miriam Kidron ...
    ... WASHINGTON , June 28 Harris Corporation (NYSE: ... Inc., is helping to improve the quality of military patient ... Information Exchange (BHIE) interface.  The exchange is a health enterprise ... the Department of Veterans Affairs (VA) to securely share patient ...
    Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 2Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 3Harris Corporation Leverages CONNECT Solution to Enhance Patient Information Exchange Between DoD and VA 2
    (Date:8/20/2014)... -- A group representing U.S. obstetricians is calling for ... According to the American College of Obstetricians and Gynecologists ... the safety and effectiveness of flu vaccination during pregnancy. ... be particularly dangerous to pregnant women, as it can ... Riley, chair of the college,s Immunization Expert Work Group, ...
    (Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
    (Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... and other minor infections might trigger a strong but brief ... study suggests. Just five out of 100,000 children a ... Heather Fullerton, lead author of the study and a professor ... Francisco Benioff Children,s Hospital. "It seems infections play a role ...
    (Date:8/20/2014)... The Board of Directors of top international ... pleased to announce the expansion of its healthcare ... and the surrounding region. In support of this strategic ... has relocated to the firm’s office in Shanghai, China, ... design and to better support regional clients. , ...
    (Date:8/20/2014)... 20, 2014 With 3943.8% growth, Connexion Point ... the nation’s fastest growing companies. The Inc. 500 ranks Connexion ... sector. Connexion Point is the #1 fastest growing company in ... and Medicaid, and its clients include four of the top ... 1,000 people and has offices and contact centers in Salt ...
    Breaking Medicine News(10 mins):Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2
    ... M.D., president and CEO of the Regenstrief Institute and ... University School of Medicine, received a 2011 Distinguished Investigator ... Education Meeting on April 28 in Washington, DC. ... and Contribution to Clinical and Translational Science. He is ...
    ... Australia and Europe. Large resources are set aside for research ... the research field is still new but researchers from ... years ago the Norwegian health care system had a low ... sectors", says Professor Karina Aase at the University of Stavanger. ...
    ... Injecting a tissue spacer in the prostate-rectal inter-space is ... prostate cancer patients receiving radiation therapy, according to research ... Radiation Therapy Symposium in Atlanta. This symposium is sponsored ... Radiological Society of North America (RSNA)., Even though prostate ...
    ... 3D models, produced by combining a patient,s CT scans ... planning. 3D printing technology is a fast ... planning. Radiologists are able to transform ultra high-resolution CT ... color printer commonly used in architecture, engineering and construction. ...
    ... HealthDay Reporter , THURSDAY, April 28 (HealthDay News) -- Men ... risk for developing potentially fatal blood clots, though overall the ... The researchers report that extra weight and extra inches together ... "Tall and obese men had more than a fivefold higher ...
    ... , THURSDAY, April 28 (HealthDay News) -- Two ... treated have been unanimously recommended for approval by a panel ... Drug Administration advisory committee voted 18-0 that telaprevir, made by ... high rate of rashes that has been reported among those ...
    Cached Medicine News:Health News:Tierney named 2011 Clinical and Translational Research Distinguished Investigator 2Health News:Sustaining vulnerable lives 2Health News:Sustaining vulnerable lives 3Health News:Tissue spacers reduce risk of rectal injury for prostate cancer patients 2Health News:Tall, Obese Men More Prone to Leg Clots: Study 2Health News:New Hepatitis C Drugs Close to Gaining FDA Approval 2Health News:New Hepatitis C Drugs Close to Gaining FDA Approval 3
    The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
    ... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
    ... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
    ... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
    Medicine Products: